Naproxen
NDC 69097-852, Naproxen, tablet, delayed release, from Cipla USA Inc..
- Product NDC
- 69097-852
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091432
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-852 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN500 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-852-07 | 69097085207 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (69097-852-07) |
| 69097-852-12 | 69097085212 | 500 TABLET, DELAYED RELEASE in 1 BOTTLE (69097-852-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e06c2b43-9882-442e-8413-10d9a33aecb9
Use it
Look up 69097-852 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-852 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-852. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.